The Victorian Government in collaboration with Johnson & Johnson Innovation JLABS today announced the Victorian QuickFire Challenge, a competition giving healthcare entrepreneurs the chance to transform their ground-breaking research into the products that will advance the well-being of people around the world.
The Victorian QuickFire Challenge is focused on ‘Driving Device Innovation’ and offers people working on health care devices in the early stage of development the chance to take their projects to the next level.
Up to three winners will share in $300,000 of grant money and receive access to Johnson & Johnson Innovation’s prestigious global mentoring and development resources.
Johnson & Johnson Innovation runs QuickFire Challenges around the world, and has chosen Victoria for its global reputation for innovation and excellence in medical technology and pharmaceuticals.
The Victorian QuickFire Challenge was announced today at the opening of the new Johnson & Johnson Innovation Partnering Office at Monash University (JJIPO@MONASH).
The JJIPO@MONASH partnering office, located at Monash University’s Clayton Campus in Melbourne, will work across Victoria’s life science ecosystem to accelerate the development of early-stage healthcare solutions that address significant unmet patient needs.
It will also nurture the next generation of innovators by delivering training, mentoring and networking programs connecting with stakeholders across the global Johnson & Johnson Innovation network.
Through start-up initiatives such as MedTech’s Got Talent, the new MedTech Actuator and BioCurate, the Victorian Government is working to capitalise upon this enormous opportunity for Victoria’s booming medtech and pharmaceutical sector, which currently employs more than 23,000 and brings in $12.7 billion in annual revenue.
Medical device innovators with projects in the early stages of development or commercialisation will be able to find out more about the Victorian QuickFire Challenge by visiting Johnson & Johnson Innovation, JLABS in the coming weeks.